The revenue of the in-vitro diagnostics market in 2017 was estimated at $63bn and was dominated by the Point of Care Testing Segment. The Molecular Diagnostics segment will be the fastest growing segment in the first-half of the forecast period.
How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 263-page report you will receive 107 tables and 81 figures– all unavailable elsewhere.
The 263-page report provides clear detailed insight into the in-vitro diagnostics market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• In-Vitro Diagnostics market forecasts from 2018-2028
• This report breaks down the revenue forecast for the main submarkets by Type: • Point of care • Clinical chemistry • Immunochemistry • Haematology • Microbiology • Molecular Diagnostics • Flow Cytometry • Others
• The Point of Care Diagnostic submarket is further segmented into: • Blood Glucose Testing • Infectious Disease Testing • Rapid Coagulation Testing • Cholesterol Testing • Pregnancy Testing
• The Clinical Chemistry submarket is further segmented into: • Basic Metabolic Panel • Electrolyte Panel • Liver Profile • Lipid Profile • Thyroid Function Test
• The Immunochemistry submarket is further segmented into: • ELISA • Immuno-PCR • Rapid Test • Western Blot • Enzyme linked Immunospot Assay
• This report breaks down the revenue forecast for the main submarkets by Application: • Infectious Diseases • Diabetes • Cardiology • Autoimmune Diseases • Renal Diseases • Pharmacogenomics • HIV/AIDS • Other Applications
• This report breaks down the revenue forecast for the main submarkets by Products & Services: • Analyzers • Reagents • Software & Services
• This report breaks down the revenue forecast for the main submarketsby End-User: • Lab Testing • Hospital Testing • University Testing • Home Care Testing
• This report provides individual revenue forecasts to 2028 for these regional and national markets: • Americas: US, Canada, Mexico, Brazil, Rest of Americas • Europe: UK, Germany, France, Spain, Italy, Russia, Rest of Europe • Asia: India, China, Japan, Rest of Asia • RoW
Each regional and national market is further segmented by type.
• Our study includes SWOT analysis and STEP analysis of the in-vitro diagnostics market.
• Our study discusses the selected leading companies that are the major players in the in-vitro diagnostics market: • Abbott Diagnostics • Agilent Technologies • Becton, Dickinson and Company (BD) • BioMerieux • Bio-Rad • Danaher Corporation • DiaSorin Diagnostics s.p.a • Roche Diagnostics • Siemens Diagnostics • Sysmex Corporation
Visiongain’s study is intended for anyone requiring commercial analyses for the in-vitro diagnostics market. You find data, trends and predictions.
Buy our report today In-Vitro Diagnostics World Market Analysis : Point of Care, Clinical Chemistry, Immunochemistry, Haematology, Microbiology, Molecular Diagnostics, Flow Cytometry, Infectious Diseases, Diabetes, Cardiology, Autoimmune Diseases, Renal Diseases, Pharmacogenomics, HIV/AIDS, Reagent & Kits, Instruments, Data Management Software & Services, Hospitals, Laboratories, Home Care Testing, Research Institutes, Blood Glucose Testing, Infectious Disease Testing, Rapid Coagulation Testing, Cholesterol Testing, Pregnancy Testing, Basic Metabolic Panel, Electrolyte Panel, Liver Profile, Lipid Profile, Thyroid Function Test, ELISA, Immuno-PCR, Rapid Test, Western Blot, Enzyme linked Immunospot Assay
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
1. Report Overview
1.1 Introduction to the IVD Industry and Market
1.2 Main Report Findings
1.3 This Study Provides the Following Knowledge
1.4 Why You Should Read This Report
1.5 How This Report Delivers
1.6 Main Questions Answered by This Study
1.7 Who is This Study For?
1.8 Research Methods and Analysis
1.9 Frequently Asked Questions (FAQ)
1.10 Associated Visiongain Reports
1.11 About Visiongain
2. Introduction to the IVD Market
2.1 Market Definition
2.2 Classifying In Vitro Diagnostics
2.2.1 The US Classification
2.2.2 The European Commission (EC) Classification
2.2.2.1 Introduction to the New IVD Regulation
2.2.2.2 Scope of Regulated IVD Products
2.2.2.3 Classification and conformity assessment
2.2.2.4 Identification and traceability
2.2.2.5 Performance evaluation report
2.2.2.6 Vigilance and market surveillance
2.2.2.7 Notified Bodies
2.2.2.8 Timetable for introduction and transition
2.2.3 Regulatory Issues in the IVD Market
2.2.3.1 Regulation of IVD Tests
2.2.3.2 Lack of Clarity Can be Costly
2.3 Market Segmentation
2.4 What are the Different Types of IVD Tests?
2.5 Point of care Diagnostics – The Most Prominent Type of IVD
2.6 Clinical Chemistry is increasing in Complexity
2.7 Microbiology
2.7.1 Regulatory Differences with IVD Microbiology Tests
2.8 Haematology
2.9 Immunochemistry
2.10 Molecular Diagnostics
2.11 Flow Cytometry
3. The Global In Vitro Diagnostics Market, 2018-2028
3.1 In Vitro Diagnostics Market in 2017
3.2 Global IVD Market Forecast 2018-2028
3.3 In Vitro Diagnostics Market in 2028
3.4 In Vitro Diagnostics Market Dynamics
3.4.1 Drivers
3.4.1.1 Advances in Technology Driving the IVD Market
3.4.1.2 Growing Partnership of Diagnostic companies with Pharmaceutical companies
3.4.1.3 Increased Awareness of the Need for IVD Tests
3.4.2 Restraints
3.4.2.1 Lack of Budget and Labour
4. The Global In Vitro Diagnostics Market, Industry Trends, 2018-2028
4.1 Mergers & Acquisitions in Liquid Biopsy Area
4.2 Growing Importance of Microbiome Research
4.3 Gene Editing Market to flourish during the forecast
4.4 Connectivity through Cloud Computing to drive POC testing market
4.5 IVD manufacturers to move beyond their boundaries to explore emerging markets
5. In Vitro Diagnostics Submarkets, 2018-2028
5.1 Point of Care Testing (POCT) Market, 2018-2028
5.2 POC Diagnostics: Market Forecast 2018-2028
5.3 POC Diagnostics: Market Dynamics 2018-2028
5.3.1 New Tests Targeting Biomarkers Will Be Crucial
5.3.2 Competition Driving Consolidation and Product Innovation
5.3.3 Infectious Diseases Prompting Growth of POC
5.3.4 Shortage of Manpower to boost the POCT market
5.3.5 Improved Data Analysis and Data Storage has fuelled the growth of POCT industry
5.3.6 Stringent Regulatory Policies affecting the new product launches
5.3.7 Product Recalls impacting the usage of POCT
5.4 POC Diagnostics Market by Sub-Segment, 2018-2028
The Alzheimer’s Disease Therapeutics and Diagnostics Market will reach $7.93bn in 2018. The Alzheimer’s Disease Therapeutics and Diagnostics Market is...
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.” Dr Luz Chapa Azuella, Mexico
The global AI-based Clinical Trial Solution Providers market was valued at US$1,232.0 million in 2022 and is projected to grow at a CAGR of 23.3% during the forecast period 2023-2033.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
